5-(Piperidin-4-yl)-2-(trifluoromethyl)pyridine hydrochloride, 97%, 5g

2-Bromo-4-methyl-n-(propan-2-yl)aniline, 95%, 1g

2,6-Dimethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 98%, 250mg

3-METHYLQUINOXALIN-5-AMINE, 95.0%, 1g

8-BROMO-2,4-DICHLORO-6-METHOXYQUINAZOLINE, 95.0%, 100mg

2-(2,3-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 5g

((4-Bromobenzyl)oxy)(tert-butyl)dimethylsilane, 95+%, 5g

tert-Butyl 6-oxo-3-azabicyclo[3.2.0]heptane-3-carboxylate, 95.0%, 100mg

S-Methylisothiourea Sulfate>98.0%(T)25g

(S)-3-Aminopentanoic acid hydrochloride, 97.0%, 100mg

1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 98%, 5g

Fmoc-L-Cystéine-(Trityl), PEPTIPURE®, min 98,5 %, pour la biochimie, 100 g, emballage en verre

tert-Butyl 7-hydroxy-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-5(6H)-carboxylate, 95%, 100mg